Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunity Persistence of Sinovac Varicella Vaccine 6 and 10 Years After Booster
NCT06484686Phase 4Enrolling by invitation
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Sep 2024
- Primary completion
- Dec 2028
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of varicella vaccine live in varicella (VZV), sponsored by Sinovac Biotech Ltd.. Started Sep 2024; status: enrolling by invitation.
02
Drugs
varicella vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT06484686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06484686.